Article History
Received: 26 January 2022
Accepted: 3 July 2022
First Online: 14 July 2022
Declarations
:
: The study was conducted as part of a research project by Fetal Precision LLC. The company has since dissolved, and the findings have been open-sourced. M. G. Frasch has patents on aECG (WO2018160890) and EEG technologies for fetal monitoring (US9215999). The authors declare that the research was conducted in the absence of any other commercial or financial relationships that could be construed as a potential conflict of interest.
: Each survey participant was first given the option to opt out of the survey (Question 1). Only if agreed to continue, were the subsequent questions shown. Due to the completely anonymous nature of the data collection and the provided right to opt out of the survey or agree to continue, no IRB approval was obtained prior to the survey’s completion. However, after the completion of the survey and prior to publication of the findings, we consulted the UW IRB. It was determined that the approach taken meets the definition of “minor non-compliance” with IRB approved procedures/UW policies and procedures, because it posed no significant increase in risk or any decrease in benefits to subjects. The IRB ruled that this means that the data collected as part of this research cannot be described as part of a study reviewed by human subject division (IRB). On January 24, 2022, the IRB determined that the corrective actions described in the report are sufficient. No additional actions are required at this time.
Free to read: This content has been made available to all.